BlackRock Fund Advisors’s West Pharmaceutical WST Stock Holding History

BlackRock Fund Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$239M	Buy	2,815,523 +119,024	+4%	+$9.36M	0.04%	509
2016 Q3	$201M	Buy	2,696,499 +106,257	+4%	+$8.44M	0.04%	537
2016 Q2	$197M	Sell	2,590,242 -960,353	-27%	-$69.9M	0.04%	508
2016 Q1	$246M	Sell	3,550,595 -61,788	-2%	-$3.72M	0.06%	383
2015 Q4	$218M	Buy	3,612,383 +144,062	+4%	+$8.67M	0.05%	439
2015 Q3	$188M	Sell	3,468,321 -771,702	-18%	-$45M	0.05%	471
2015 Q2	$246M	Buy	4,240,023 +7,967	+0.2%	+$445K	0.06%	376
2015 Q1	$255M	Buy	4,232,056 +247,009	+6%	+$13.2M	0.06%	361
2014 Q4	$212M	Buy	3,985,047 +365,910	+10%	+$18.3M	0.05%	418
2014 Q3	$162M	Sell	3,619,137 -47,762	-1%	-$2.03M	0.05%	499
2014 Q2	$155M	Sell	3,666,899 -233,265	-6%	-$9.99M	0.04%	555
2014 Q1	$172M	Buy	3,900,164 +67,439	+2%	+$3.17M	0.05%	455
2013 Q4	$188M	Buy	3,832,725 +73,202	+2%	+$3.43M	0.06%	399
2013 Q3	$155M	Buy	3,759,523 +420,467	+13%	+$16M	0.05%	446
2013 Q2	$117M	Buy	+3,339,056	New	+$110M	0.04%	548

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BlackRock Fund Advisors's WST Position: Q4 2016 in Review

BlackRock Fund Advisors increased its West Pharmaceutical (WST) stake by 4.4% in Q4 2016, buying an estimated $9.36M and bringing the position to 2,815,523 shares worth $239M. The position accounts for 0.04% of the portfolio, ranked #509.

BlackRock Fund Advisors first reported a position in WST in Q2 2013 and has held it in 15 quarters since. The position peaked at $255M in Q1 2015. 287 funds tracked by Wall St. Rank hold WST as of Q4 2016.

BlackRock Fund Advisors held 2,815,523 shares of West Pharmaceutical worth $239M as of Q4 2016.
BlackRock Fund Advisors bought 119,024 West Pharmaceutical shares in Q4 2016, an estimated $9.36M.
West Pharmaceutical made up 0.04% of BlackRock Fund Advisors's portfolio in Q4 2016, its #509 holding.
BlackRock Fund Advisors first reported a position in West Pharmaceutical in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's West Pharmaceutical position peaked at $255M in Q1 2015.
287 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.